SFM
FLNA

Soros Fund Management’s Filana Therapeutics FLNA Stock Holding History

Soros Fund Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,100
Closed -$38K – 277
2015
Q2 		$38K Buy
+3,100
New +$42.5K ﹤0.01% 239
2014
Q2 		– Sell
-14,814
Closed -$570K – 426
2014
Q1 		$570K Buy
+14,814
New +$523K 0.01% 262

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Soros Fund Management's FLNA Position: Q3 2015 in Review

Soros Fund Management sold out of Filana Therapeutics (FLNA) in Q3 2015, closing a stake of 3,100 shares — an estimated $38K sold.

Soros Fund Management first reported a position in FLNA in Q1 2014 and held it in 2 quarters. The position peaked at $570K in Q1 2014. 49 funds tracked by Wall St. Rank hold FLNA as of Q3 2015.

  • Soros Fund Management reported no remaining Filana Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Soros Fund Management sold 3,100 Filana Therapeutics shares in Q3 2015, an estimated $38K.
  • Soros Fund Management first reported a position in Filana Therapeutics in Q1 2014 and held it in 2 quarters.
  • Soros Fund Management's Filana Therapeutics position peaked at $570K in Q1 2014.
  • 49 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2015.

Based on Soros Fund Management's 13F filing for Q3 2015, filed 16 Nov 2015.